Skip to main content

Table 1 Characteristics of study groups

From: Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo

Variables

Healthy Control

Patients with Vitiligo

P-value

Subjects (n)

25

25

-

Sex (male/female)

18/7

18/7

0.551*

Age, years, mean ± SD

31.23 ± 6.81

30.47 ± 9.03

0.627#

Body mass index (BMI), kg/m2, mean ± SD

23.66 ± 3.02

22.81 ± 4.05

0.181#

Smoking, n (%)

7 (28)

5 (20)

0.742*

Alcohol consumption, n (%)

9 (36)

6 (24)

0.538*

Diet n (%)

  

0.703*

High protein diets

6 (24)

5 (20)

 

High carbohydrate diets

8 (32)

6 (24)

 

High fiber diets

5 (20)

4 (16)

 

Balanced dieters

6 (24)

10 (40)

 

Vitiligo Disease Activity(VIDA) score, mean ± SD

-

2.80 ± 1.08

 

Type of vitiligo

-

Non-segmental

 

Activity of vitiligo

-

Advanced

 

Disease Duration, month, mean ± SD

-

41.28 ± 50.28

 

Family history (%)

-

4 (16%)

 
  1. *Fisher. test
  2. #Wilcoxon. test